Financials

%ChgLast 12MReverse

	FY202512/31/2025	Last 12M06/30/2026
Cash and Cash Equivalents	415.4	425.3
Short Term Investments	73.7	499.9
Cash and Short Term Investments	489.1	925.2
Net Receivables	2.3	-
Inventory	0.2	0.3
Other Current Assets	-0.0	12.4
Total Current Assets	500.9	937.9
Property, Plant & Equipment	9.2	27.9
Long Term Investments	-	-
Other Non-Current Assets	20.6	21.2
Total Non-Current Assets	45.1	49.4
Total Assets	545.9	987.2
Account Payables	104.1	90.4
Short Term Debt	-	-
Deferred Revenue	-	-
Other Current Liabilities	6.6	1.3
Total Current Liabilities	129.5	106.4
Long Term Debt	-	-
Other Non-Current Liabilities	0.0	-
Total Non-Current Liabilities	0.0	2.9
Total Liabilities	129.5	109.3
Common Stock	396.9	407.9
Retained Earnings	-1,695.2	-
Total Stockholders Equity	416.4	878.0
Total Liabilities and Equity	545.9	987.2

TransThera Sciences (Nanjing). Inc. Class H(2617 HK)